Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China-Reference-Cited by-同舟云学术

Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China

Published:2011-07-05 Issue:7 Volume:6 Page:e21836
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shang Penghui,Xia Yinyin,Liu Feiying,Wang Xiaomeng,Yuan Yanli,Hu Daiyu,Tu Dehua,Chen Yixin,Deng Peiyuan,Cheng Shiming,Zhou Lin,Ma Yu,Zhu Lizhen,Gao Weiwei,Wang Hongyuan,Chen Dafang,Yang Li,He Pingping,Wu Shanshan,Tang Shaowen,Lv Xiaozhen,Shu Zheng,Zhang Yuan,Yang Zhirong,Chen Yan,Li Na,Sun Feng,Li Xiaoting,He Yingjian,Garner Paul,Zhan Siyan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Global tuberculosis control: WHO Report 2010,2010

2. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).;YY Xia;BMC Public Health,2010

3. The effect of tuberculosis control in China.;Lancet,2004

4. An expanded DOTS framework for effective tuberculosis control. Stop TB Communicable Diseases,2002

5. Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers.;WJ Burman;Am J Respir Crit Care Med,2001

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced liver injury in tropical settings;Treatment and Management of Tropical Liver Disease;2025

2. Research on the treatment of rifampin-susceptible tuberculosis—Time for a new approach;PLOS Medicine;2024-07-25

3. Continuous Rifampicin Therapy Induced Acute Kidney Injury in a Tuberculous Patient: A Case Report;International Journal of Medical Students;2024-07-09

4. Longitudinal metabolomics of human plasma reveal metabolic dynamics and predictive markers of antituberculosis drug-induced liver injury;Respiratory Research;2024-06-21

5. Comprehensive Therapeutic Approaches to Tuberculous Meningitis: Pharmacokinetics, Combined Dosing, and Advanced Intrathecal Therapies;Pharmaceutics;2024-04-14